Literature DB >> 3709315

Metachronous colorectal cancer. Time interval to presentation of a metachronous cancer.

P J Kiefer, A G Thorson, M A Christensen.   

Abstract

A retrospective review of 1888 colorectal cancer patients demonstrated 37 metachronous cancers in 30 patients for a metachronous cancer rate of 1.6 percent. Evaluation of the index cancers consisted of the traditional single-contrast barium enema and proctoscopic evaluation. Forty percent of the metachronous cancers appeared within two years of the index cancer. If the minimum length of the polyp-cancer sequence is three to five years, then this represents a failure of a traditional preoperative evaluation. A more sensitive evaluation potentially could decrease the metachronous cancer rate. Colonoscopy, which has been found to be more accurate in detecting synchronous neoplasms, should be included in the evaluation of all patients with colorectal cancers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709315     DOI: 10.1007/bf02555051

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  6 in total

1.  Metachronous colorectal cancer in Taiwan: analyzing 20 years of data from Taiwan Cancer Registry.

Authors:  Tzu-An Chen; Jorng-Tzong Horng; Wen-Chu Lin
Journal:  Int J Clin Oncol       Date:  2012-02-07       Impact factor: 3.402

2.  Metachronous colorectal malignancies.

Authors:  Devaji Rao; Sangeetha Jayaraman
Journal:  Indian J Surg       Date:  2011-04-09       Impact factor: 0.656

3.  Haemoccult does not reduce the need for colonoscopy in surveillance after curative resection for colorectal cancer.

Authors:  C Hall; J Griffin; P W Dykes; J A Williams; M R Keighley
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

4.  Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma.

Authors:  Hong-Zhi Wang; Xin-Fu Huang; Yi Wang; Jia-Fu Ji; Jin Gu
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

5.  Synchronous and metachronous adenocarcinomas of the large intestine.

Authors:  N Tziris; J Dokmetzioglou; K Giannoulis; I Kesisoglou; K Sapalidis; E Kotidis; O Gambros
Journal:  Hippokratia       Date:  2008-07       Impact factor: 0.471

6.  Clinicopathological features and surgical options for synchronous colorectal cancer.

Authors:  Byoung Chul Lee; Chang Sik Yu; Jihun Kim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.